Myasthenia Gravis
Myasthenia gravis is characterized by the
weakness and rapid fatigue under your voluntary control of any of the muscles. It is caused by a breakdown in normal nervous / muscular communication. There is no cure for
myasthenia gravis but treatment may help relieve signs and symptoms such as arm or leg muscle weakness, double vision, drooping eyelids, and speech, chewing , swallowing, and breathing difficulties. Although this disease may affect people of any age, it is more common in women under 40 and men over 60 years of age. While
myasthenia gravis can affect all of the muscles you volunteer to monitor, some muscle groups are more commonly affected than others. Muscle
weakness caused by
myasthenia gravis worsens with use of the affected muscle. Since symptoms tend to improve with rest, muscle
weakness can come and go.
High Impact List of Articles
-
High rate of asymptomatic hypoglycemia in insulin-treated diabetes with severe chronic kidney disease: Utility of flash interstitial glucose monitoring
Connie Luo, Maria Ines Constantino, Margaret Joy McGill, Timothy Middleton, Ted Wu, Jencia Wong, Stephen Morris Twigg & P Jean Ho*
Research Article: Diabetes Management
-
High rate of asymptomatic hypoglycemia in insulin-treated diabetes with severe chronic kidney disease: Utility of flash interstitial glucose monitoring
Connie Luo, Maria Ines Constantino, Margaret Joy McGill, Timothy Middleton, Ted Wu, Jencia Wong, Stephen Morris Twigg & P Jean Ho*
Research Article: Diabetes Management
-
Feeding behavior of patients with type 2 diabetes living at Cotonou, Benin
Alassani A, Dovonou Ac, Gninkoun J, Wanvoegbe A, Azandjeme C, Jerome S, Attinsounon A, Gomina M, Mizehoun AC, Codjo L, Ade S, Amoussou-Guenou D & Djrolo F
Research Article: Diabetes Management
-
Feeding behavior of patients with type 2 diabetes living at Cotonou, Benin
Alassani A, Dovonou Ac, Gninkoun J, Wanvoegbe A, Azandjeme C, Jerome S, Attinsounon A, Gomina M, Mizehoun AC, Codjo L, Ade S, Amoussou-Guenou D & Djrolo F
Research Article: Diabetes Management
-
Biomarkers of diabetic retinopathy
Jose Cunha-Vaz, Luisa Ribeiro, Sandrina Nunes & Conceicao Lobo
Review Article: Diabetes Management
-
Biomarkers of diabetic retinopathy
Jose Cunha-Vaz, Luisa Ribeiro, Sandrina Nunes & Conceicao Lobo
Review Article: Diabetes Management
-
Is there anything positive about iatrogenic hypoglycemia in Type 1 diabetes?
Bastiaan E de Galan
Editorial: Diabetes Management
-
Is there anything positive about iatrogenic hypoglycemia in Type 1 diabetes?
Bastiaan E de Galan
Editorial: Diabetes Management
-
Molecular action and pharmacogenetics of metformin: current understanding of an old drug
Graham Rena, Ewan R Pearson& Kei Sakamoto
Review Article: Diabetes Management
-
Molecular action and pharmacogenetics of metformin: current understanding of an old drug
Graham Rena, Ewan R Pearson& Kei Sakamoto
Review Article: Diabetes Management
Relevant Topics in Clinical